Medline Industries

Medline Industries's reported carbon emissions

Medline Industries, a US-based company operating in the medical, precision and optical instruments, watches and clocks sector, reported total carbon emissions of approximately 5.09 billion kg CO2e in 2024. This figure encompasses Scope 1, 2, and 3 emissions. In 2023, the company's total emissions were approximately 7.28 billion kg CO2e. Breaking down these figures, Scope 1 emissions stood at about 133.23 million kg CO2e in 2024, and Scope 2 emissions (market-based) were approximately 141.26 million kg CO2e in the same year. Scope 3 emissions, which are significantly larger, amounted to approximately 4.81 billion kg CO2e in 2024, with purchased goods and services representing the largest contributor at about 3.14 billion kg CO2e. In 2023, Scope 1 emissions were approximately 173.84 million kg CO2e and Scope 2 emissions were around 131.90 million kg CO2e. Medline Industries has established climate commitments, including ambitious reduction scenarios for near-term (by 2030) and long-term (by 2050). Specifically, the company is committed to reducing its Scope 1 and Scope 2 emissions by 30% from a 2023 baseline by 2030. There is also a goal to achieve near-zero Scope 1 and 2 emissions by the middle of the current decade. Furthermore, Medline aims for an absolute reduction of 42% for combined Scope 1 and Scope 2 emissions by 2030, based on a 2022 baseline. For Scope 3 emissions, a reduction target of 25% is set for 2030. The company is also committed to achieving Net Zero emissions by 2050. It's important to note that Medline Industries' emissions data is cascaded from its parent organisation, Medline Industries, Inc., at cascade level 1.